Literature DB >> 21436073

Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase.

Erin M Parry1, Jonathan K Alder, Xiaodong Qi, Julian J-L Chen, Mary Armanios.   

Abstract

Mutations in the essential telomerase components hTERT and hTR cause dyskeratosis congenita, a bone marrow failure syndrome characterized by mucocutaneous features. Some (~ 3%) sporadic aplastic anemia (AA) and idiopathic pulmonary fibrosis cases also carry mutations in hTERT and hTR. Even though it can affect clinical outcome, because the mutation frequency is rare, genetic testing is not standard. We examined whether the cooccurrence of bone marrow failure and pulmonary fibrosis in the same individual or family enriches for the presence of a telomerase mutation. Ten consecutive individuals with a total of 36 family members who fulfilled these criteria carried a germline mutant telomerase gene (100%). The mean age of onset for individuals with AA was significantly younger than that for those with pulmonary fibrosis (14 vs 51; P < .0001). Families displayed autosomal dominant inheritance and there was an evolving pattern of genetic anticipation, with the older generation primarily affected by pulmonary fibrosis and successive generations by bone marrow failure. The cooccurrence of AA and pulmonary fibrosis in a single patient or family is highly predictive for the presence of a germline telomerase defect. This diagnosis affects the choice of bone marrow transplantation preparative regimen and can prevent morbidity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436073      PMCID: PMC3110022          DOI: 10.1182/blood-2010-11-322149

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

2.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.

Authors:  Hiroki Yamaguchi; Rodrigo T Calado; Hinh Ly; Sachiko Kajigaya; Gabriela M Baerlocher; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  N Engl J Med       Date:  2005-04-07       Impact factor: 91.245

3.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.

Authors:  Hiroki Yamaguchi; Gabriela M Baerlocher; Peter M Lansdorp; Stephen J Chanock; Olga Nunez; Elaine Sloand; Neal S Young
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

4.  Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantation.

Authors:  M Yabe; H Yabe; K Hattori; T Morimoto; T Hinohara; I Takakura; T Shimizu; K Shimamura; X Tang; S Kato
Journal:  Bone Marrow Transplant       Date:  1997-02       Impact factor: 5.483

5.  Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita.

Authors:  Mary Armanios; Jiunn-Liang Chen; Yen-Pei Christy Chang; Robert A Brodsky; Anita Hawkins; Constance A Griffin; James R Eshleman; Alan R Cohen; Aravinda Chakravarti; Ada Hamosh; Carol W Greider
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

6.  The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita.

Authors:  T Vulliamy; A Marrone; F Goldman; A Dearlove; M Bessler; P J Mason; I Dokal
Journal:  Nature       Date:  2001-09-27       Impact factor: 49.962

7.  Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation.

Authors:  Richard C Allsopp; Gregg B Morin; Ronald DePinho; Calvin B Harley; Irving L Weissman
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

8.  Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA.

Authors:  Patrick F Fogarty; Hiroki Yamaguchi; Adrian Wiestner; Gabriela M Baerlocher; Elaine Sloand; Weihua S Zeng; Elizabeth J Read; Peter M Lansdorp; Neal S Young
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

9.  Dyskeratosis congenita: advances in the understanding of the telomerase defect and the role of stem cell transplantation.

Authors:  Josu de la Fuente; Inderjeet Dokal
Journal:  Pediatr Transplant       Date:  2007-09

10.  Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis.

Authors:  Jonathan K Alder; Joy D Cogan; Andrew F Brown; Collin J Anderson; William E Lawson; Peter M Lansdorp; John A Phillips; James E Loyd; Julian J-L Chen; Mary Armanios
Journal:  PLoS Genet       Date:  2011-03-31       Impact factor: 5.917

View more
  67 in total

Review 1.  Telomerase and idiopathic pulmonary fibrosis.

Authors:  Mary Armanios
Journal:  Mutat Res       Date:  2011-11-04       Impact factor: 2.433

2.  Telomeres: All's well that ends well.

Authors:  Michael Eisenstein
Journal:  Nature       Date:  2011-10-12       Impact factor: 49.962

Review 3.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

4.  Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Authors:  Valeriya Gaysinskaya; Susan E Stanley; Soheir Adam; Mary Armanios
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

5.  Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.

Authors:  Amany I Gorgy; Naudia L Jonassaint; Susan E Stanley; Ayman Koteish; Amy E DeZern; Jolan E Walter; Sabrina C Sopha; James P Hamilton; Julie Hoover-Fong; Allen R Chen; Robert A Anders; Ihab R Kamel; Mary Armanios
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

6.  Telomerase reverse transcriptase and Wnt signaling.

Authors:  Katherine L Friedman
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

7.  Telomere length is a determinant of emphysema susceptibility.

Authors:  Jonathan K Alder; Nini Guo; Frant Kembou; Erin M Parry; Collin J Anderson; Amany I Gorgy; Michael F Walsh; Thomas Sussan; Shyam Biswal; Wayne Mitzner; Rubin M Tuder; Mary Armanios
Journal:  Am J Respir Crit Care Med       Date:  2011-07-14       Impact factor: 21.405

8.  Telomere dysfunction causes alveolar stem cell failure.

Authors:  Jonathan K Alder; Christina E Barkauskas; Nathachit Limjunyawong; Susan E Stanley; Frant Kembou; Rubin M Tuder; Brigid L M Hogan; Wayne Mitzner; Mary Armanios
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-03       Impact factor: 11.205

9.  Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

Authors:  Kristen E Schratz; Lisa Haley; Sonye K Danoff; Amanda L Blackford; Amy E DeZern; Christopher D Gocke; Amy S Duffield; Mary Armanios
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

Review 10.  Extrahematopoietic manifestations of the short telomere syndromes.

Authors:  Kristen E Schratz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.